July 2019 - Page 3 of 4 - CanadianCannabisWire

ThursdayJul 11, 2019 12:13 pm

Geyser Brands Inc. (TSX.V: GYSR) Strengthens Leadership with Key Appointments

Seasoned life sciences executive Dr. Bin Huang has been appointed to the Geyser board of directors Chartered Professional Account Gordon Clissold has been named chief executive officer Geyser Brands is entering into a definitive agreement for the acquisition of Solace Management Group, which will broaden the company’s range of CBD- and hemp-based products Geyser Brands Inc. (TSX.V: GYSR), a leading consumer health care company based in Vancouver, British Columbia, builds health-based hemp CBD consumer products in the worldwide nutraceutical, cosmetics, food & beverage and pet sectors. Recent pivotal appointments to Geyser Brand’s leadership team are expected to strengthen the company’s…

ThursdayJul 11, 2019 11:36 am

Willow Biosciences Inc. (CSE: WLLW) Developing Biosynthesis Platform for Production of Low-Cost, Pharmaceutical-Grade CBD

A joint development agreement signed with Noramco Inc., the world’s largest producer of chemically synthesized cannabinoids and pharmaceutical APIs, is expected to scale the development of Willow’s CBD biosynthesis program The collective market for CBD sales in the U.S. is expected to exceed $20 billion by 2024, while the cannabinoid-based pharmaceuticals market may reach $50 billion by 2029 Synthetic biology is expected to disrupt the cannabinoid industry supply chain, providing access to new and larger markets for CBD and related compounds Willow Biosciences Inc. (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (APIs)…

ThursdayJul 11, 2019 10:33 am

Growth of Organic Farming Providing Opportunities for Natural Biopesticide Companies Like MustGrow Biologics Corp. (CSE: MGRO)

Organic farming is forecast to grow at a CAGR of 8.4 percent through 2026, fueled by high demand and concerns about the use of traditional agricultural practices The organic pesticide market is also expected to expand, at a CAGR of approximately 14.9 percent through 2023 These market dynamics show that companies like MustGrow Biologics that specialize in biopesticides and biofertilizers could benefit from significant growth opportunities As the global organic farming market continues growing at a sustainable and consistent rate, new expansion opportunities emerge for organizations such as MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company that develops and…

WednesdayJul 10, 2019 10:13 am

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Releases Financial Results, Announces Strategic Accomplishments for Fiscal 2019

Sproutly’s financial results for fiscal 2019 show that the company has accomplished a number of important milestones Highlights included finalization of the company’s acquisition of Infusion Biosciences Canada and the completion of Sproutly’s Greater Toronto Area production facility The next phase of operations involves the launch of Sproutly’s premium flower under the CALIBER brand Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G), a company engaged in developing and bringing to market cannabis products, recently announced its financial results and most important strategic accomplishments for fiscal year 2019, which ended on February 28, 2019. Keith Dolo, Sproutly’s CEO, said that…

TuesdayJul 09, 2019 11:34 am

Video Outlines Benefits of Willow Biosciences Inc.’s (CSE: WLLW) JDA to Develop CBD through Biosynthesis

Canada-based Willow Biosciences and U.S.-based Noramco are teaming to biosynthetically produce and market pharmaceutical-grade cannabidiol (CBD) The companies expect to deliver yeast-cultivated CBD as a low-cost, ultra-pure alternative to cannabis cultivation that avoids large-scale plant waste from greenhouse processes Yeast-grown pharmaceutical ingredients have long served as fodder for insulin and other important drugs; the growing interest in cannabis as a therapy is driving a booming new market The sea change in societal attitudes about cannabis, accompanied by the opening of governmental regulatory doors for its use (http://cnw.fm/2FTo9), has spawned a land rush by corporate interests set on staking out market territory…

TuesdayJul 09, 2019 11:01 am

Geyser Brands Inc. (TSX.V: GYSR) Reaches Milestone in CBD Wellness Market with Reception of Processing License

Geyser Brands is a cannabis consumer wellness company dedicated to helping people look, feel and do their best The company announced June 18 that wholly owned subsidiary Apothecary Botanicals has been awarded a processing license, allowing GYSR to advance its brands Geyser’s LOI to acquire Solace Management Group is expected to give the company additional wellness brands for humans and their pets, once due diligence is completed Consumer wellness brand cultivator Geyser Brands Inc. (TSX.V: GYSR) is moving forward with its vision of developing premier cannabis-enhanced products following Health Canada’s announcement that the company’s wholly owned subsidiary, Apothecary Botanicals (0957102…

TuesdayJul 09, 2019 10:38 am

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Consumer Access with Retail Partnerships for CBD Product Lines

Wildflower Brands has completed a distribution deal that places its CBD-based SKUs at nearly 300 Dillard’s stores nationwide Wildflower’s products are also being sold through bohemian lifestyle outlet Free People, which is labeling the products as part of its Beauty and Wellness Collection Wildflower’s success has led to the hiring of a second shift of employees at its Washington production facility and the start of construction of a new facility to keep pace with demand Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is getting its cannabis-based wellness products into an expanding number of consumers’ hands through retail partnerships that are…

MondayJul 08, 2019 10:11 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Leading the Way in Effective Cannabis Treatment

Lexaria developed and out-licenses DehydraTECH to create new (and improve existing) drug-delivery products The company is credited with leading the way forward in discovering new ways to effectively deliver CBD into the human body Lexaria is helping firms meet supply and demand requirements by creating products that offer lower dosing with higher absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is known for its innovative delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. The company developed drug-delivery platform DehydraTECH and out-licenses the platform to create new (and improve existing) orally ingested…

WednesdayJul 03, 2019 10:59 am

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Closes Initial Share Purchase of Cannova Medical Ltd.

Nabis Holdings has closed on its previously announced initial purchase of a 49 percent interest in Cannova Medical Ltd., with an option to purchase the remaining 51 percent The company selected Cannova Medical for its unique approach to consumable cannabis technology and untapped industry potential Nabis sees Cannova as a potential disruptor in the edible cannabis industry Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company pursuing specialty investment opportunities in the burgeoning cannabis industry (among others), recently announced that it has now completed the purchase of a 49 percent interest in Cannova Medical Ltd.,…

TuesdayJul 02, 2019 11:20 am

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Readies for Canada’s Second Cannabis Wave with Successful Run of APP Extraction Process

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids Deloitte estimates that Canada’s cannabis edibles and topicals market could be worth $2.7 billion annually The company has entered into an exclusive joint venture with Moosehead Breweries Limited to develop and produce nonalcoholic, cannabis-infused beverages Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) has reached another milestone by successfully completing the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc., Sproutly CEO and Director Keith Dolo announced in a news release (http://cnw.fm/kQP6M).…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977

Month: July 2019